menu
    • menu

    Company profile for OncoMyx Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement. Our MYXV platform, spun-out from Arizona State University (ASU), is poised to be a best-in-class OV approa...
    OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement. Our MYXV platform, spun-out from Arizona State University (ASU), is poised to be a best-in-class OV approach. We have assembled the top OV team around MYXV to advance a pipeline of oncology therapeutics for the benefit of cancer patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OncoMyx TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Phoenix BioScience Center 445 N. Fifth Street, Phoenix, AZ 85004
    Telephone
    Telephone
    (602) 567-8064
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncomyx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/oncomyx
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OncoMyx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OncoMyx Presents New Data at AACR 2022 on Multi-Armed Myxoma Virus Coordinates
    OncoMyx Presents New Data at AACR 2022 on Multi-Armed Myxoma Virus Coordinates

    08 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220408005021/en

    BUSINESSWIRE
    08 Apr 2022
    Share Share
    OncoMyx Appoints Robert Williamson Chief Business and Chief Financial Officer
    OncoMyx Appoints Robert Williamson Chief Business and Chief Financial Officer

    02 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220302005314/en

    BUSINESSWIRE
    02 Mar 2022
    Share Share
    OncoMyx nabs $50M to jump into the clinic
    OncoMyx nabs $50M to jump into the clinic

    08 Dec 2021

    // Ben Adams FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/oncomyx-nabs-50m-to-jump-into-clinic-its-rabbit-pox-virus-cancer-drug

    Ben Adams FIERCEBIOTECH
    08 Dec 2021
    Share Share
    Underpinning Sinema’s outspoken opposition to major drug pricing reforms
    Underpinning Sinema’s outspoken opposition to major drug pricing reforms

    19 Oct 2021

    // Nicholos Florko STATNEWS

    https://www.statnews.com/2021/10/19/arizona-biotechs-kyrsten-sinema-drug-pricing-reforms/

    Nicholos Florko STATNEWS
    19 Oct 2021
    Share Share
    OncoMyx Gets Exclusive Option to License IP Rights for Myxoma Virus Technology
    OncoMyx Gets Exclusive Option to License IP Rights for Myxoma Virus Technology

    15 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210615005459/en

    BUSINESSWIRE
    15 Jun 2021
    Share Share
    OncoMyx's modified rabbit pox virus shows promise in lung cancer
    OncoMyx's modified rabbit pox virus shows promise in lung cancer

    13 Apr 2021

    // Angus Liu FIEREBIOTECH

    https://www.fiercebiotech.com/research/oncomyx-s-engineered-rabbit-pox-virus-shows-more-power-against-cancer

    Angus Liu FIEREBIOTECH
    13 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search